Pharmanutra S.p.A. (BIT:PHN)
Italy flag Italy · Delayed Price · Currency is EUR
74.70
-1.10 (-1.45%)
At close: Mar 27, 2026

Pharmanutra Cash Flow Statement

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
2016.6112.8315.0513.77
Depreciation & Amortization
3.93.342.421.151.01
Other Amortization
-0.17---
Provision & Write-off of Bad Debts
-0.140.210.170.15
Other Operating Activities
1.111.191.410.811.26
Change in Accounts Receivable
-2.87-2.982.22-5.15-1.77
Change in Inventory
-1.911.22-2.91-2.4-0.97
Change in Accounts Payable
4.11.43-0.787.142.58
Change in Income Taxes
-1.30.022.55-3.043.59
Change in Other Net Operating Assets
-3.39-0.7-5.873.740.81
Operating Cash Flow
19.5620.512.0917.4720.41
Operating Cash Flow Growth
-4.58%69.56%-30.77%-14.44%73.02%
Capital Expenditures
-3.13-4.25-13.25-26.16-4.99
Sale of Property, Plant & Equipment
0.020.660.550.270.08
Investment in Securities
---0.25-
Other Investing Activities
-0.251.38-2.01-1.08-0.64
Investing Cash Flow
-3.36-2.21-14.7-26.72-5.54
Long-Term Debt Issued
0.80.6210.9915.415.41
Total Debt Issued
0.80.6210.9915.415.41
Long-Term Debt Repaid
-4.56-6.11-0.7-4.04-0.72
Total Debt Repaid
-4.56-6.11-0.7-4.04-0.72
Net Debt Issued (Repaid)
-3.76-5.4910.2911.384.69
Issuance of Common Stock
0.11----
Repurchase of Common Stock
-1.33-0.55-1.65-2.36-
Common Dividends Paid
-9.59-8.17-7.71-6.85-6.49
Other Financing Activities
1.45-7.38-1.44-0.27-0.12
Financing Cash Flow
-13.12-21.59-0.521.89-1.92
Net Cash Flow
3.08-3.31-3.13-7.3612.95
Free Cash Flow
16.4316.25-1.16-8.6915.43
Free Cash Flow Growth
1.10%---52.49%
Free Cash Flow Margin
12.26%13.99%-1.15%-10.46%22.64%
Free Cash Flow Per Share
1.721.69-0.12-0.901.59
Levered Free Cash Flow
16.0512.862.25-14.6711.35
Unlevered Free Cash Flow
16.7313.532.75-14.6311.36
Change in Working Capital
-5.37-1.01-4.780.294.23
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.